logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
L

Lyudmila Bazhenova

University of California System

53H-index
438Paper Count
1.7WCitation Count
Published Papers 78
Publication Date
logo
Circulating Biomarkers and Targeted Therapy in Pleural Mesothelioma
errCancers 2025, Vol. 17, Page 3863
IF4.4
err2025-12-01
err0
errOAAI
errChristopher R. Grant; Lyudmila Bazhenova; Karen M. Yun
errShare
errSave
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer
errLung Cancer
IF4.4
err2025-09-07
err0
PREAI
errFangdi Sun; Mandeep K. Banwait; Surbhi Singhal; Amanda Herrmann; Zofia Piotrowska; Karen Yun; Lyudmila Bazhenova; Ayman T. Ullah; Emily W. Guo; Heather A. Wakelee; Joel W. Neal; Millie S. Das; Kavitha J. Ramchandran; Mohana Roy; Maximilian Diehn; Nathaniel J. Myall
errShare
errSave
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non–Small-Cell Lung Cancer According to ALK Fusion and Mutation Status
errClinical Lung Cancer
IF3.3
err2025-06-06
err0
errOAAI
errLyudmila Bazhenova; J.G. Hodgson; D. Ross Camidge; Corey J. Langer; Rudolf M. Huber; Dong-Wan Kim; Karen L. Reckamp; Myung-Ju Ahn; Daniel S.W. Tan; Jyoti D. Patel; Sylvie Vincent; Cong Li; Michael J. Humphries; Pingkuan Zhang; Victor M. Rivera; Scott Gettinger
errShare
errSave
Second line advanced or metastatic non-small cell lung cancer treatment after chemo-immunotherapy: a retrospective study
errFUTURE ONCOLOGY
IF2.6
err2025-03-01
err0
errOAAI
errBazhenova, Lyudmila; Cai, Beilei; Gentile, Danielle; Kish, Jonathan; Feinberg, Bruce
errShare
errSave
Taletrectinib vs repotrectinib in ROS1-positive (ROS1+) nonesmall cell lung cancer (NSCLC): A matching-adjusted indirect comparison (MAIC)
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errNagasaka, M.; Liu, G.; Pennell, N.; Ohe, Y.; Perol, M.; Li, S.; Chen, M.; Bazhenova, L.; Zhou, C.
errShare
errSave
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study
errFUTURE ONCOLOGY
IF2.6
err2024-11-08
err0
errOAAI
errBazhenova, Lyudmila; Kim, Dong-Wan; Cho, Byoung Chul; Goel, Sanjay; Heist, Rebecca; Werner, Theresa L.; Eaton, Keith D.; Wang, Judy S.; Pant, Shubham; Adkins, Douglas R.; Blakely, Collin M.; Yan, Xiaohong; Neuteboom, Saskia; Christensen, James G.; Chao, Richard; Bauer, Todd
errShare
errSave
Pooled efficacy and safety from 2 pivotal phase II trials of taletrectinib in patients (Pts) with advanced or metastatic ROS1+non-small cell lung cancer (NSCLC)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err2
PREAI
errPerol, M.; Li, W.; Pennell, N. A.; Liu, G.; Ohe, Y.; De Braud, F. G. M.; Nagasaka, M.; Felip, E.; Xiong, A.; Zhang, Y.; Fan, H.; Wang, X.; Yan, B.; Li, S.; Chen, M.; Bazhenova, L.; Zhou, C.
errShare
errSave
Efficacy and safety of taletrectinib in patients (Pts) with ROS1+non-small cell lung cancer (NSCLC): Interim analysis of global TRUST-II study
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err3
errOAAI
errPerol, M.; Yang, N.; Choi, C-M.; Ohe, Y.; Sugawara, S.; Yanagitani, N.; Liu, G.; De Braud, F. G. M.; Nieva, J.; Nagasaka, M.; Bazhenova, L.; Zhou, C.; Felip, E.; Zhang, X.; Li, S.; Pennell, N. A.
errShare
errSave
ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study
errTARGETED ONCOLOGY
IF4
err2023-06-21
err5
errOAAI
errWang, Michelle; Slatter, Shadera; Sussell, Jesse; Lin, Chia-Wei; Ogale, Sarika; Datta, Debajyoti; Butte, Atul J.; Bazhenova, Lyudmila; Rudrapatna, Vivek A.
errShare
errSave
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)
errJCO CLINICAL CANCER INFORMATICS
IF2.8
err2023-04-01
err2
PREAI
errLee, Shing M.; Fan, Weijia; Wang, Aijin; Vaidya, Riha; Redman, Mary W.; Gettinger, Scott N.; Bazhenova, Lyudmila; Herbst, Roy S.; Hershman, Dawn L.; Unger, Joseph M.
errShare
errSave
Exploring the role of accessory biomarkers TMB, STK11, KEAP1, and KRAS in non-small-cell lung cancer: confused, but on a much higher level
errANNALS OF ONCOLOGY
IF65.4
err2023-04-01
err2
PREAI
errBazhenova, L.
errShare
errSave
Phase II trial of trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC): Registrational data from DESTINY-Lung01
errANNALS OF ONCOLOGY
IF65.4
err2022-09-01
err2
PREAI
errLi, B. T.; Smit, E. F.; Goto, Y.; Nakagawa, K.; Goto, K.; Mazieres, J.; Uprety, D.; Bazhenova, L.; Saltos, A.; Felip, E.; Pacheco, J.; Perol, M.; Paz-Ares, L.; Saxena, K.; Shiga, R.; Cheng, Y.; Yan, Q.; Planchard, D.; Janne, P. A.
errShare
errSave
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2022-07-14
err451
errOAAI
errJaenne, Pasi A.; Riely, Gregory J.; Gadgeel, Shirish M.; Heist, Rebecca S.; Ou, Sai-Hong I.; Pacheco, Jose M.; Johnson, Melissa L.; Sabari, Joshua K.; Leventakos, Konstantinos; Yau, Edwin; Bazhenova, Lyudmila; Negrao, Marcelo V.; Pennell, Nathan A.; Zhang, Jun; Anderes, Kenna; Der-Torossian, Hirak; Kheoh, Thian; Velastegui, Karen; Yan, Xiaohong; Christensen, James G.; Chao, Richard C.; Spira, Alexander I.
errShare
errSave
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
errCANCER DISCOVERY
IF33.3
err2022-04-11
err59
errOAAI
errWang, Mengzhao; Yang, James Chih-Hsin; Mitchell, Paul L.; Fang, Jian; Camidge, D. Ross; Nian, Weiqi; Chiu, Chao-Hua; Zhou, Jianying; Zhao, Yanqiu; Su, Wu-Chou; Yang, Tsung-Ying; Zhu, Viola W.; Millward, Michael; Fan, Yun; Huang, Wen-Tsung; Cheng, Ying; Jiang, Liyan; Brungs, Daniel; Bazhenova, Lyudmila; Lee, Chee Khoon; Gao, Bo; Xu, Yan; Hsu, Wei-Hsun; Zheng, Li; Janne, Pasi A.
errShare
errSave
Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small-cell lung cancer after TKI therapy
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2022-03-01
err11
errOAAI
errYu, Li; Bazhenova, Lyudmila; Gold, Kathryn; Tran, Lisa; Hilburn, Van; Vu, Peter; Patel, Sandip Pravin
errShare
errSave
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors
errCLINICAL CANCER RESEARCH
IF10.2
err2022-02-10
err112
errOAAI
errDemetri, George D.; De Braud, Filippo; Drilon, Alexander; Siena, Salvatore; Patel, Manish R.; Cho, Byoung Chul; Liu, Stephen, V; Ahn, Myung-Ju; Chiu, Chao-Hua; Lin, Jessica J.; Goto, Koichi; Lee, Jeeyun; Bazhenova, Lyudmila; John, Thomas; Fakih, Marwan; Chawla, Sant P.; Dziadziuszko, Rafal; Seto, Takashi; Heinzmann, Sebastian; Pitcher, Bethany; Chen, David; Wilson, Timothy R.; Rolfo, Christian
errShare
errSave
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2022-01-20
err533
errOAAI
errLi, Bob T.; Smit, Egbert F.; Goto, Yasushi; Nakagawa, Kazuhiko; Udagawa, Hibiki; Mazieres, Julien; Nagasaka, Misako; Bazhenova, Lyudmila; Saltos, Andreas N.; Felip, Enriqueta; Pacheco, Jose M.; Perol, Maurice; Paz-Ares, Luis; Saxena, Kapil; Shiga, Ryota; Cheng, Yingkai; Acharyya, Suddhasatta; Vitazka, Patrik; Shahidi, Javad; Planchard, David; Janne, Pasi A.
errShare
errSave
Repotrectinib in patients with NTRK fusion-positive advanced solid tumors: update from the registrational phase 2 TRIDENT-1 trial
errMOLECULAR CANCER THERAPEUTICS
IF5.5
err2021-12-01
err5
PREAI
errBesse, Benjamin; Baik, Christina; Springfeld, Christoph; Hervieu, Alice; Moreno, Victor; Bazhenova, Lyudmila; Lin, Jessica J.; Camidge, D. Ross; Solomon, Benjamin; Velcheti, Vamsidhar; van der Wekken, Anthonie J.; Felip, Enriqueta; Uprety, Dipesh; Trone, Denise; Stopatschinskaja, Shanna; Cho, Byoung Chul; Drilon, Alexander
errShare
errSave
Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET: Update from the Phase 1 SHIELD-1 trial
errMOLECULAR CANCER THERAPEUTICS
IF5.5
err2021-12-01
err4
PREAI
errHong, David S.; Catenacci, Daniel; Bazhenova, Lyudmila; Cho, Byoung Chul; Ponz-Sarvise, Mariano; Heist, Rebecca; Moreno, Victor; Falchook, Gerald; Zhu, Viola W.; Swalduz, Aurelie; Besse, Benjamin; Kim, Dong-Wan; Yoon, Shinkyo; Le, Xiuning; Zhao, Tingting; Kadva, Alysha; Zimmerman, Zachary; Lee, Jeeyun
errShare
errSave
Primary data from DESTINY-Lung01: A phase II trial of trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC)
errANNALS OF ONCOLOGY
IF65.4
err2021-09-01
err0
errOAAI
errLi, B. T.; Smit, E. F. F.; Goto, Y.; Nakagawa, K.; Udagawa, H.; Mazieres, J.; Nagasaka, M.; Bazhenova, L.; Saltos, A. N.; Felip, E.; Pacheco, J. M.; Perol, M.; Paz-Ares, L.; Saxena, K.; Shiga, R.; Cheng, Y.; Acharyya, S.; Shahidi, J.; Planchard, D.; Janne, P. A.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
M
Mark G. Kris
H-index: 149 · Papers: 1.4K
R
Razelle Kurzrock
H-index: 144 · Papers: 2.3K
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
R
Roy S. Herbst
H-index: 134 · Papers: 1.3K
View more